Home›Elevated PSA

Elevated PSA: what it means and what comes next

Getting a prostate-specific antigen result above the reference range is immediately alarming. Let's start with the most important point: an elevated PSA is not a diagnosis of cancer. It is a finding that calls for further study, not a verdict.

What PSA is

Prostate-specific antigen is a protein produced by the prostate that circulates in small amounts in the blood. It is measured in nanograms per millilitre (ng/mL) and forms part of the assessment of prostate health, alongside physical examination and, where appropriate, imaging.

The key phrase is prostate-specific, not cancer-specific. Anything that irritates, inflames or enlarges the gland can raise the figure. That is why the number on its own is almost never enough to make a decision.

The essential point

Most men with an elevated PSA do not have prostate cancer. Benign causes are considerably more common.

Dr. Eduardo Amaya Fragoso

Written and reviewed by

Dr. Eduardo Amaya Fragoso

Urologic Surgeon · Fellowship in Urologic Oncology (Centro Médico Nacional Siglo XXI · UNAM) · International Fellow in Robotic Urology (Instituto Israelita Albert Einstein, Brazil)

Professional Licence 10407470 · Specialty Licence 12943253 · CONAMEU 1918 (valid 2022–2027). Practice at Hospital San José, Hermosillo, Sonora.

Last reviewed: 23 July 2026

Why PSA can rise

These are the causes ruled out first, because they are the most common:

  • Benign prostatic enlargement (hyperplasia). The larger the prostate, the more PSA it produces. This is an age-related process.
  • Prostatitis or urinary infection. This can raise PSA markedly but temporarily; it should be treated and the test repeated weeks later.
  • Urinary retention or recent instrumentation: catheter placement, cystoscopy or a previous biopsy.
  • Recent ejaculation or prolonged cycling in the days before the test.
  • Age. The reference value is not the same at 50 as it is at 70.

In the opposite direction, some medications lower the figure: finasteride and dutasteride, used for prostatic enlargement, reduce it by roughly half. If you take them it is essential to say so, because a "normal" value under their effect may be masking a real elevation.

What alters itBy how muchHow long to wait before repeating
Prostatitis or urinary infectionCan multiply it several times over6 to 8 weeks after finishing treatment
Urinary retentionConsiderably2 weeks after it has been resolved
Previous biopsy or instrumentationConsiderably6 weeks
Recent ejaculationSlightly48 hours
Cycling or hard exerciseSlightly48 hours
Digital rectal examinationMinimally, without clinical relevanceNo need to wait
Benign prostatic enlargementIn proportion to prostate volumeNot applicable: the rise is sustained and is interpreted using PSA density
Finasteride or dutasterideHalves itThe value must be doubled in order to interpret it

The row that delays the most diagnoses

The last one. If you take finasteride or dutasteride for the prostate or for hair loss, your real PSA is roughly double the figure on the report. A value of 2 in a patient taking these drugs is equivalent to 4, and that changes management entirely. It is frequently missed because the patient does not mention it and nobody asks.

The number alone is not enough

An isolated figure says little. What genuinely guides the decision is the context, and that includes several elements:

  • Confirmation. Repeating the test under appropriate conditions, after ruling out infection, prevents unnecessary procedures.
  • PSA kinetics. How it has changed over time carries more information than a single value.
  • Free PSA. The ratio between the free and total fractions helps estimate how likely it is that the rise is benign.
  • PSA density. This relates the figure to prostate volume: a large gland justifies a higher PSA.
  • Physical examination. The digital rectal exam still provides information no blood test replaces.
  • Family history. First-degree relatives with prostate cancer and other factors change the interpretation.

MRI before biopsy

For years, an elevated PSA led straight to biopsy. Today the usual sequence is different: a multiparametric MRI of the prostate is performed first, allowing the gland to be seen in detail and suspicious areas to be graded on a standardised scale.

That change brings two concrete advantages. When there is a suspicious lesion, the biopsy is targeted to it rather than sampling at random, which improves accuracy. And when the study shows no relevant lesions, in selected cases it allows biopsy to be avoided and surveillance continued instead.

When a biopsy is indicated

The indication is individualised and depends on the whole picture: the value and its trend, the MRI findings, the examination, age and family history. There is no automatic figure above which everyone must be biopsied.

When it is indicated, image-guided sampling is performed under anaesthesia with appropriate prophylaxis. It is an outpatient procedure, explained step by step before scheduling, including the risks and the aftercare.

And if the result is cancer

It helps to know this now, because it changes how the waiting feels: not every prostate cancer is operated on. There are low-risk tumours for which active surveillance — scheduled follow-up with periodic testing, without immediate treatment — is a valid and safe option.

When treatment is required, the main alternatives are surgery — including robot-assisted radical prostatectomy — and radiotherapy, with or without hormone therapy depending on the case. The choice depends on the risk of the tumour, age, coexisting conditions and each patient's priorities.

If the diagnosis is already made

If your biopsy confirmed a tumour confined to the prostate, the guide on localized prostate cancer explains how risk is classified and what the options are, including not treating yet.

If your prostate is enlarged

Benign prostatic enlargement is one of the most frequent causes of a raised PSA. The guide on enlarged prostate and HoLEP explains when treatment is worthwhile.

Before anyone puts a needle in your prostate

Why it matters who looks after you

An elevated PSA is not a diagnosis: it is the beginning of a chain of decisions. And in that chain, the expensive mistakes are made before the biopsy, not during it.

  • Deciding whether a biopsy is needed at allAn isolated number does not justify one. The size of the prostate must be weighed, along with how fast the value rose, whether there was recent prostatitis or instrumentation, and whether you take finasteride or dutasteride, which halve the PSA. Many men are biopsied unnecessarily, while others have their PSA repeated for years when they should already have been investigated.
  • MRI first, not afterwardsMultiparametric MRI makes it possible to avoid unnecessary biopsies and, where a biopsy is warranted, to direct it at the lesion rather than sampling at random. It requires someone able to read it and translate it into a plan.
  • Doing the biopsy properlyA biopsy targeted by fusion with the MRI finds the tumours that matter and stops finding the ones that do not. A poorly performed biopsy creates two problems: false negatives that delay diagnosis, and irrelevant findings that lead to overtreatment.
  • And if it is cancer, not starting from scratchHere the path continues without changing doctor or records: risk classification, staging, and whatever treatment applies —surgery included— with the person who has known your case since the first PSA.

I am not saying others do it badly. I am saying that the decision to biopsy or not to biopsy matters as much as the biopsy itself, and that whoever makes it should be someone who knows what to do with either result.

A urologic oncologist is a urologist who additionally completed a postgraduate fellowship devoted solely to urological cancer. Mine was at Centro Médico Nacional Siglo XXI, accredited by UNAM. It can be verified. What exactly changes →

What to bring to your appointment

  • Every PSA result you have, with its date, even from previous years.
  • Previous imaging studies (ultrasound, MRI, CT) on disc or with digital access.
  • The pathology report, if you have already had a biopsy.
  • A list of your medications, particularly finasteride or dutasteride.
  • Family history of prostate, breast or ovarian cancer.
390+ verified patient reviews on DoctoraliaDoctoralia Excellence Certificate

Very professional. He took the time to listen to my symptoms so that he could reach a diagnosis based on an ultrasound. Very satisfied with his professionalism.

M.A.E Verified appointment · Doctoralia · translated from Spanish

See all on Doctoralia

Dr. Eduardo Amaya Fragoso

Urologic Oncologist · Robotic Surgeon

Dr. Eduardo Amaya Fragoso

Do you have an elevated PSA and don't know what comes next?

Bring your results — every PSA you have, the MRI if it has been done, the pathology report if there was a biopsy — and we will review them together. I will explain what they show, what they do not show, and what your real options are.

Available in person and by video consultation

Where I practise

Hospital San José, Hermosillo

Suite 301 · Module H · 3rd floor
Blvd. José María Morelos 340, Col. Bachoco, ZIP 83148
Hermosillo, Sonora

Appointments & info

662 111 0782

Hours

Monday to Friday · 8:00 AM – 8:00 PM

Saturday · 9:00 AM – 2:00 PM

Coming from another city? Travel times, length of stay and remote follow-up

Loading map…

Note

This information is for general guidance and does not replace a medical consultation. Every case needs individual assessment: do not make decisions about tests or treatment based on this text without discussing it with your urologist.

Message on WhatsApp Call · 662 111 0782 Book on Doctoralia Emergency